Other safety alerts
|
| |
| The United States: FDA warns consumers not to use Balguti Kesaria Ayurvedic Medicine due to high levels of lead |
| |
The US Food and Drug Administration (FDA) issues update warning about Balguti Kesaria Ayurvedic Medicine. An FDA laboratory analyzed a sample of the product and confirmed it contained lead in addition to arsenic, and mercury. FDA continues to warn parents and caregivers to not use this product. Exposure to these heavy metals could lead to serious adverse health effects. Anyone who is using the product or giving it to a child should stop immediately and see a health care provider to be evaluated for potential heavy metal poisoning.
Please refer to the following website in FDA for details:
http://www.fda.gov/Drugs/DrugSafety/ucm570237.htm
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by FDA, and was posted on the Drug Office website on 5 Aug 2017.
Ends/Friday, Nov 3, 2017
Issued at HKT 13:00
|
| |
|
